MARION CRISOSTOMO: Open Payments
NPI 1558134353 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 28 payments from 9 companies in 2025. Trend: 2023 $139 · 2024 $1,878 · 2025 $1,017
Food & beverage: $1,017
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $361 |
| ABBVIE INC. | 11 | $273 |
| Vanda Pharmaceuticals Inc. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $94 |
| Axsome Therapeutics, Inc. | 1 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $21 |
| Lundbeck LLC | 1 | $13 |
Products named: CAPLYTA, VRAYLAR, FANAPT, REXULTI, Auvelity, TRINTELLIX, LYBALVI, LOREEV XR.
Industry payments across AZ — which companies pay providers there.
